MCM
VRTX icon

MAI Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

MAI Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
5,638
+3,420
+154% +$1.52M 0.01% 614
2026
Q1 		$990K Sell
2,218
-346
-13% -$161K 0.01% 780
2025
Q4 		$1.16M Buy
2,564
+718
+39% +$309K 0.01% 692
2025
Q3 		$723K Sell
1,846
-281
-13% -$117K ﹤0.01% 810
2025
Q2 		$947K Buy
2,127
+209
+11% +$96.3K 0.01% 666
2025
Q1 		$930K Buy
1,918
+22
+1% +$10.3K 0.01% 637
2024
Q4 		$764K Sell
1,896
-522
-22% -$242K 0.01% 722
2024
Q3 		$1.12M Sell
2,418
-1,220
-34% -$586K 0.01% 523
2024
Q2 		$1.71M Buy
3,638
+257
+8% +$112K 0.02% 449
2024
Q1 		$1.41M Buy
3,381
+665
+24% +$281K 0.01% 480
2023
Q4 		$1.11M Buy
2,716
+212
+8% +$78.3K 0.01% 439
2023
Q3 		$871K Sell
2,504
-361
-13% -$126K 0.01% 463
2023
Q2 		$1.01M Sell
2,865
-170
-6% -$57.3K 0.01% 428
2023
Q1 		$956K Buy
3,035
+7
+0.2% +$2.1K 0.02% 434
2022
Q4 		$874K Buy
3,028
+470
+18% +$143K 0.01% 441
2022
Q3 		$741K Buy
2,558
+262
+11% +$75.4K 0.01% 440
2022
Q2 		$647K Sell
2,296
-91
-4% -$24.4K 0.01% 479
2022
Q1 		$623K Buy
2,387
+622
+35% +$148K 0.01% 501
2021
Q4 		$388K Buy
1,765
+108
+7% +$21K 0.01% 640
2021
Q3 		$301K Buy
+1,657
New +$324K 0.01% 623

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MAI Capital Management's VRTX Position: Q2 2026 in Review

MAI Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 154% in Q2 2026, buying an estimated $1.52M and bringing the position to 5,638 shares worth $2.8M. The position accounts for 0.01% of the portfolio, ranked #614.

MAI Capital Management first reported a position in VRTX in Q3 2021 and has held it in 20 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • MAI Capital Management held 5,638 shares of Vertex Pharmaceuticals worth $2.8M as of Q2 2026.
  • MAI Capital Management bought 3,420 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.52M.
  • Vertex Pharmaceuticals made up 0.01% of MAI Capital Management's portfolio in Q2 2026, its #614 holding.
  • MAI Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.